通过机械化学方法从基于循环德克斯的包容复合物中控制释放达沙替尼:一项计算和实验研究
Katarina Sokač1, Lucija Vrban2, Marin Liović3
1University of Zagreb, Faculty of Chemical Engineering and Technology, Department of Mechanical and Thermal Process Engineering, Trg Marka Marulića 19, 10 000 Zagreb, Croatia.
International journal of pharmaceutics
|April 5, 2025
概括
这项研究开发了一种控制释放的达沙替尼b配方,使用环极来改善溶解性并减少白血病治疗中的副作用. 新配方增强了药物输送和患者的遵守性.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 达沙替尼是一种氨酸激酶抑制剂,面临着水溶性差和高第一通代谢的挑战,导致生物可用性和潜在毒性有限.
- 达沙提尼布在血液中的快速度峰值可以加剧严重的副作用,如心脏毒性和肝毒性.
研究的目的:
- 开发使用环氧的控制释放达沙替尼的配方,以提高溶解性和生物可用性.
- 调查循环德克斯特林纳入复合物的潜力,以减轻达沙替尼的不良影响和改善治疗结果.
主要方法:
- 使用机械化学合成制备达沙提尼布-循环德的包括复合物.
- 使用固态和基于溶液的方法对复杂化和药物无形化的表征.
- 分子动力学模拟以阐明达沙替尼布-环德林结合相互作用.
主要成果:
- 证实了达沙替尼与环极素的成功复杂化和无形化.
- 分子动力学模拟提供了对药物与宿主相互作用的见解.
- 配方药片表现出增强的溶解性和改善的体外药物释放概况.
结论:
- 环极素有效地与达沙提尼布形成包括综合体,增强其溶解性,并使其可控释放.
- 这种配方方法显示出降低达沙替尼的毒性和提高其在白血病治疗中的治疗疗效的潜力.
- 该研究强调了环极素作为有前途的载体,可以改善达沙替尼的药理动力学和安全性.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
103
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
103
Modified-Release Drug Delivery Systems: Drug Release Characteristics
225
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
225
Modified-Release Drug Delivery Systems: Classification
289
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
289
Modified-Release Drug Delivery Systems: Rate-Programmed I
133
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
133
Modified-Release Drug Delivery Systems: Stimuli-Activated
140
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
140
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127


